Adam Crystal Tango Therapeutics, Inc. (TNGX) insider trading activity

Adam Crystal is of Tango Therapeutics, Inc.. Currently has a direct ownership of 158,210 shares of TNGX, which is worth approximately $530,003. The most recent transaction as insider was on Feb 05, 2025, when has been sold 6,851 shares (Common Stock) at a price of $3.16 per share, resulting in proceeds of $21,649. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 158K

32.42% 3M change

32.42% 12M change

Total Value Held $530,003

Adam Crystal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 05 2025	SELL Open market or private sale	$21,649 $3.16 p/Share	6,851 Reduced 4.15%	158,210 Common Stock
Feb 04 2025	SELL Open market or private sale	$22,221 $2.99 p/Share	7,432 Reduced 4.31%	165,061 Common Stock
Feb 03 2025	BUY Grant, award, or other acquisition	-	53,015 Added 23.51%	172,493 Common Stock
Feb 07 2024	SELL Open market or private sale	$51,527 $12.62 p/Share	4,083 Reduced 3.3%	119,478 Common Stock
Feb 06 2024	SELL Open market or private sale	$53,857 $12.56 p/Share	4,288 Reduced 3.35%	123,561 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	46,599 Added 50.0%	46,599 Common Stock
Nov 01 2023	SELL Open market or private sale	$62,983 $8.39 p/Share	7,507 Reduced 8.46%	81,250 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	81,250 Added 50.0%	81,250 Common Stock

Also insider at

CCCC

C4 Therapeutics, Inc. Healthcare

Chief Medical Officer

Adam Crystal

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNGX shares.

Notify only if

Value

Insider Trading

Get notified when an Tango Therapeutics, Inc. insider buys or sells TNGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tango Therapeutics, Inc.

Track Activities on TNGX

Account